Retractable Technologies Inc income statement

In fiscal 2025, Retractable Technologies Inc reported revenue of $38.3m, up 15.8% on the year before, operating income of −$21.2m (a -55.3% margin) and net income of −$12.6m, or −$0.43 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Retractable Technologies Inc: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	39	36	32	34	31	35	30	30	34	33	42	82	188	95	44	33	38	34
Cost of revenue	25	24	21	22	20	22	19	19	25	23	28	45	93	67	34	34	38	34
Gross profit	14	13	11	11	10	12	11	10	10	10	14	37	95	28	9	−1	0	−0
Research and development	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Selling and marketing	4	4	3	4	4	4	4	4	5	4	4	4	4	5	6	6	7	7
General and administrative	19	14	11	10	11	10	9	9	8	7	6	8	17	24	14	14	13	14
Operating income	−13	−7	−4	−4	−6	−2	−3	−4	−4	−1	3	24	73	−1	−11	−21	−21	−23
Interest expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income before tax	−13	2	1	−4	−6	−2	4	−4	−4	−1	3	26	75	5	−9	−4	−12	−3
Income tax	−4	−0	0	0	0	0	0	0	−0	−0	0	2	19	0	−2	8	0	0
Net income	−9	2	1	−4	−6	−2	4	−4	−4	−1	3	24	56	5	−7	−12	−13	−3
Diluted EPS	−$0.45	$0.04	$0.02	−$0.19	−$0.26	−$0.12	$0.20	−$0.15	−$0.14	−$0.06	$0.07	$0.80	$1.63	$0.15	−$0.24	−$0.40	−$0.43	−$0.11
Diluted shares (average)	24m	26m	26m	26m	27m	27m	29m	29m	32m	33m	33m	33m	34m	33m	30m	30m	30m	30m
EBITDA	−12	−5	−3	−3	−5	−1	−2	−3	−3	−0	4	25	74	4	−4	−14	−13	−15

US$ millions unless shown otherwise. Fiscal quarters.

Retractable Technologies Inc: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	10	9	8	10	10	9	7	7
Cost of revenue	10	12	8	11	8	11	8	7
Gross profit	−0	−2	−0	−0	2	−2	−1	0
Research and development	0	0	0	0	0	0	0	0
Selling and marketing	2	1	2	2	2	2	2	2
General and administrative	3	3	3	3	4	3	3	4
Operating income	−5	−7	−5	−5	−4	−8	−6	−5
Interest expense	0	0	0	0	0	0	0	0
Income before tax	−2	4	−10	−0	0	−2	−4	3
Income tax	−0	0	0	0	0	0	0	0
Net income	−2	4	−11	−0	0	−2	−4	3
Diluted EPS	−$0.07	$0.13	−$0.35	$0.00	$0.01	−$0.08	−$0.14	$0.09
EBITDA	−3	−5	−3	−3	−2	−6	−4	−3

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: OBIO vs RVP RVP vs UTMD POCI vs RVP ECOR vs RVP

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Retractable Technologies Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Retractable Technologies Inc.